Toxic chemicals in menstrual products reflect systemic failures in corporate accountability, regulatory oversight, and gendered health inequities
Original framing: “Menstrual pads and tampons can contain toxic substances – here’s what to know about this emerging health issue” — The Conversation - Global
The original framing omits the historical parallels of toxic exposure in other consumer products, the lack of Indigenous and traditional knowledge in menstrual health solutions, and the structural causes of gendered health inequities. Marginalized voices, particularly those of low-income women and non-binary individuals, are often excluded from discussions about product safety and regulatory standards.
Medium structural omission detected in mainstream coverage.
This narrative is produced by academic and media institutions that often center Western biomedical perspectives, serving a global audience concerned with consumer safety. The framing obscures the power dynamics of corporate influence in regulatory bodies and the historical marginalization of menstrual health in policy. It also overlooks the role of colonial and patriarchal structures in shaping health priorities.
Scientific studies have consistently found harmful chemicals in menstrual products, yet regulatory bodies often fail to act due to industry lobbying and weak enforcement mechanisms. This gap highlights the need for independent, long-term research on product safety.
The presence of toxic chemicals in menstrual products is a systemic issue rooted in corporate negligence, weak regulation, and gendered health disparities.